Arabic Arabic English English French French German German
dark

TellBio’s Scientific Founders Publish Very High Concordance between CTCs and ctDNA from Liquid Biopsies in Patients with Breast Cancer

TellBio, Inc. announces publication of data from the scientific founders showing high concordance of detecting ESR1 mutations in CTCs and ctDNA among patients diagnosed with ER-positive metastatic breast cancer. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

White House Enlists Social Media Giants to Suppress Vaccine ‘Misinformation’

Next Post

Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada’s National Research Council

Related Posts
Total
0
Share